patented drugs
-
Franchise India Bureau Jul 04 2018 - 3 min readSanofi sees a more diversified pipeline driving a return to growth at its diabetes unit in the coming years and will consider acquisitions and partnerships to help boost performance, a company executive said on Tuesday. The French drugmaker's diabetes revenues have fallen since 2015, slumping some 11 percent last year alone, ...
-
Franchise India Bureau May 09 2018 - 1 min readDrugmaker Strides Shasun Ltd has decided to merger Australian businesses with Apotex Inc, the company said in a stock-exchange disclosure. The transaction is subject to entering into definitive agreements, satisfactory due diligence, customary closing conditions and statutory approvals, Strides Shasun said. It didn’t disclose the deal value. The merged ...
-
Franchise India Bureau Apr 06 2018 - 1 min readDrug firm Lupin has confirmed to have received an Establishment Inspection Report (EIR) from the US health regulator for its Pithampur, Unit 1 manufacturing facility in Madhya Pradesh. The inspection was conducted in July 2017, it said in a BSE filing. USFDA gives EIR on the closure of inspection ...
-
Franchise India Bureau Mar 29 2018 - 1 min readThe US-based Pharmaceuticals Glenmark has confirmed to have received the final nod from US health regulator for its Clobetasol Propionate spray used for the treatment of moderate to severe plaque psoriasis in adults. Glenmark Pharmaceuticals received approval by the United States Food & Drug Administration (USFDA) for Clobetasol Propionate spray 0.05 percent, the company said ...
-
Franchise India Bureau Mar 22 2018 - 1 min readSuven Life Sciences has claimed to have been granted a patent each by Norway, South Korea and Singapore corresponding to new chemical entities (NCEs) for the treatment of disorders associated with neurodegenerative diseases. As per the filing registered by the company, the patents are valid till 2027, 2034 and 2036, respectively. ...